Clinical Trial of YH25448(Lazertinib) as the First-line Treatment in Patients With EGFR Mutation Positive Locally Advanced or Metastatic NSCLC (LASER301)
Clinical trial NCT04248829 · COMPLETED
Trial details
- NCT number
- NCT04248829
- Sponsor
- Yuhan Corporation
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-13
- Primary completion
- 2022-07-29
- Enrollment
- 393
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.